| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/22/1999 | WO1999036438A1 HUMAN CMRF-35-H9 RECEPTOR WHICH BINDS IgM |
| 07/22/1999 | WO1999036437A1 Antibody/receptor targeting moiety for enhanced delivery of armed ligand |
| 07/22/1999 | WO1999036434A1 Liposomes comprising peptide antigens derived from x protein of hepatitis b virus |
| 07/22/1999 | WO1999036433A2 Materials and methods for treating oncological disease |
| 07/22/1999 | WO1999036431A1 Compounds with growth hormone releasing properties |
| 07/22/1999 | WO1999036426A1 N-[2-(5-BENZYLOXYCARBONYL-AMINO-6-OXO-2-(4-FLUOROPHENYL)-1,6-DIHYDRO-1-PYRIMIDINYL)ACETO- XYL]-L-ASPARTIC ACID ALDEHYDE AS AN IN VIVO INHIBITOR OF INTERLEUKIN-1β CONVERTING ENZYME (ICE) |
| 07/22/1999 | WO1999036404A1 Bisulfate salt of hiv protease inhibitor |
| 07/22/1999 | WO1999036103A1 Prevention and treatment of neuropathy by hepatocyte growth factor |
| 07/22/1999 | WO1999036100A2 Polymeric carrier |
| 07/22/1999 | WO1999036099A1 Sustained release compositions, process for producing the same and utilization thereof |
| 07/22/1999 | WO1999036094A2 Composition and method for treating metastatic tumors or cancer induced by cells expressing sv40 tumor antigen |
| 07/22/1999 | WO1999036093A1 Methods of using human receptor protein 4-1bb |
| 07/22/1999 | WO1999036092A2 Hiv inhibition using ligand for gp60 receptor or albumin receptor on target cells |
| 07/22/1999 | WO1999036091A2 Method for inhibiting cd95-independent apoptosis in aids |
| 07/22/1999 | WO1999036089A1 Genetic immunization with co-delivery of nucleic acid and cytokines in a single vehicle |
| 07/22/1999 | WO1999036083A1 Methods of neuroendocrine regulation of affective disorders |
| 07/22/1999 | WO1999036082A2 The use of increased neurofilament protein levels as protection and therapy against neurodegeneration with oxidative stress involvement |
| 07/22/1999 | WO1999036081A1 Peptide ligands that bind to surfaces of bacterial spores |
| 07/22/1999 | WO1999030157A3 Neuropilins in methods for diagnosis and prognosis of cancer |
| 07/22/1999 | WO1999027958A3 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 07/22/1999 | WO1999027097A3 CLONING OF A TETRODOTOXIN-RESISTANT SODIUM CHANNEL α-SUBUNIT |
| 07/22/1999 | WO1999025721B1 Detection and treatment of retinal degenerative disease |
| 07/22/1999 | WO1999025690A3 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 07/22/1999 | WO1999024587A3 Human phospholipase a2 protein and dna encoding it |
| 07/22/1999 | WO1999024553A8 X-ray crystal comprising hiv-1 gp120 |
| 07/22/1999 | WO1999024052A3 Use of protein h as cytostatic agent |
| 07/22/1999 | WO1999023246A8 Methods and compositions for targeting dna metabolic processes using aminoglycoside derivatives |
| 07/22/1999 | WO1999023208A3 RIBOZYMES TARGETED TO IL-15 mRNA |
| 07/22/1999 | WO1999016457A3 Novel composition for treating, preventing and/or delaying ischemic cell death |
| 07/22/1999 | WO1999005291A3 Aggrecan degrading metallo proteases |
| 07/22/1999 | WO1998059040A3 Human catalytic telomerase sub-unit and its diagnostic and therapeutic use |
| 07/22/1999 | WO1998055495B1 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 07/22/1999 | DE19753681A1 Erythropoietin composition has a highly specific activity |
| 07/22/1999 | CA2318697A1 Human lymphoid protein tyrosine phosphatases |
| 07/22/1999 | CA2318664A1 Nucleotide expression systems with reduced immunogenicity for use in gene therapy |
| 07/22/1999 | CA2318663A1 Methods and compositions for gene delivery |
| 07/22/1999 | CA2318661A1 Transglutaminase linkage of agents to tissue |
| 07/22/1999 | CA2318660A1 Lh-receptor gene promoter for tissue-specific gene expression |
| 07/22/1999 | CA2318558A1 Compounds with growth hormone releasing properties |
| 07/22/1999 | CA2318525A1 Methods of using human receptor protein 4-1bb |
| 07/22/1999 | CA2318498A1 Genetic immunization with co-delivery of nucleic acid and cytokines in a single vehicle |
| 07/22/1999 | CA2318358A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation |
| 07/22/1999 | CA2318284A1 Antibody/receptor targeting moiety for enhanced delivery of armed ligand |
| 07/22/1999 | CA2318156A1 Mmsc1 - an mmac1 interacting protein |
| 07/22/1999 | CA2318037A1 Methods of neuroendocrine regulation of affective disorders |
| 07/22/1999 | CA2317941A1 Adenoviral vectors with modified capsid proteins |
| 07/22/1999 | CA2317895A1 Ribozymal nucleic acids cleaving ccr5 or cxcr4 |
| 07/22/1999 | CA2317815A1 Neisseria meningitidis antigens |
| 07/22/1999 | CA2317810A1 Human chemokine and its use for detection and treatment of breast disease |
| 07/22/1999 | CA2317392A1 Secreted proteins and polynucleotides encoding them |
| 07/22/1999 | CA2317094A1 Human protease molecules |
| 07/22/1999 | CA2316273A1 Sustained-release composition, method of its production and use thereof |
| 07/22/1999 | CA2309546A1 N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-l-aspartic acid aldehyde as an in vivo inhibitor of interleukin-1.beta. converting enzyme (ice) |
| 07/21/1999 | EP0930366A2 Binding domains in delta proteins |
| 07/21/1999 | EP0930365A2 Binding domains in serrate protein |
| 07/21/1999 | EP0930364A1 TWIK-1 related two domains potassium channel |
| 07/21/1999 | EP0930316A1 Oral product for the prevention and treatment of infectious gastroenteritides in calves |
| 07/21/1999 | EP0929689A2 Artifical chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 07/21/1999 | EP0929688A1 Sustained delivery device and methods of making and using the same |
| 07/21/1999 | EP0929684A2 Phospholipase d and dna sequences |
| 07/21/1999 | EP0929683A1 DIABETES MELLITUS 37 kD AUTOANTIGEN PROTEIN-TYROSINE PHOSPHATASE |
| 07/21/1999 | EP0929675A2 Nucleotide and protein sequence of mammastatin and methods of use |
| 07/21/1999 | EP0929674A2 HUMAN Bad POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USE |
| 07/21/1999 | EP0929673A2 Tumor proteins |
| 07/21/1999 | EP0929672A1 Human gtp binding protein gamma-3 |
| 07/21/1999 | EP0929671A1 Method for treating amyotrophic lateral sclerosis |
| 07/21/1999 | EP0929670A1 P-selectin ligand proteins |
| 07/21/1999 | EP0929668A1 Modulators of brca1 activity |
| 07/21/1999 | EP0929667A1 Hypertension markers |
| 07/21/1999 | EP0929664A1 Hematopoietic stem cells and methods for generating such cells |
| 07/21/1999 | EP0929578A1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 07/21/1999 | EP0929576A1 Glp-2 derivatives |
| 07/21/1999 | EP0929575A1 Novel human growth factors |
| 07/21/1999 | EP0929574A1 MODULATORS OF beta-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS |
| 07/21/1999 | EP0929572A1 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 07/21/1999 | EP0929571A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 07/21/1999 | EP0929570A1 Modified cytostatic agents |
| 07/21/1999 | EP0929569A1 Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 07/21/1999 | EP0929568A2 Pharmaceutical compositions for the treatment of immune disorders |
| 07/21/1999 | EP0929322A1 Methods and compositions for programming an organic matrix for remodeling into a target tissue |
| 07/21/1999 | EP0929314A1 Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form |
| 07/21/1999 | EP0929313A1 Regulation of neural enzymes |
| 07/21/1999 | EP0929312A1 Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester and its derivatives in disease regression |
| 07/21/1999 | EP0929311A1 INHIBITION OF APOPTOSIS USING INTERLEUKIN-1 beta-CONVERTING ENZYME (ICE)/CED-3 FAMILY INHIBITORS |
| 07/21/1999 | EP0929310A1 Diagnostic and therapeutic methods related to regulating energy mobilization with ob protein and ob antibodies |
| 07/21/1999 | EP0929306A1 Method of inhibiting smooth muscle cell proliferation |
| 07/21/1999 | EP0929270A1 Oral peptide pharmaceutical products |
| 07/21/1999 | EP0832095A4 A method of cross-linking amino acid-containing polymers using photoactivatable chemical cross-linkers |
| 07/21/1999 | EP0745092B1 Peptide inhibitors of urokinase receptor activity |
| 07/21/1999 | EP0714411B1 Process for obtaining mucoadhesive starch |
| 07/21/1999 | CN1223690A Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 07/21/1999 | CN1223689A Brain glycogen phosphorylase cancer antigen |
| 07/21/1999 | CN1223685A Modulators of tissue regeneration |
| 07/21/1999 | CN1223664A Serine protease inhibitors |
| 07/21/1999 | CN1223663A Transcription factor |
| 07/21/1999 | CN1223660A Method and compounds for curing diseases caused by mutations |
| 07/21/1999 | CN1223643A Prenyl transferase inhibitors |
| 07/21/1999 | CN1223642A Inhibitors of prenyl transferases |
| 07/21/1999 | CN1223588A Method for treating inflammation |
| 07/21/1999 | CN1223587A Method for treating or preventing ischemia-repersion injury |